Agarwal R - Search Results

1

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

Rossing P, Filippatos G, Agarwal R, Anker SD, Pitt B, Ruilope LM, Chan JCN, Kooy A, McCafferty K, Schernthaner G, Wanner C, Joseph A, Scheerer MF, Scott C, Bakris GL; FIDELIO-DKD Investigators. Rossing P, et al. Among authors: agarwal r. Kidney Int Rep. 2021 Oct 14;7(1):36-45. doi: 10.1016/j.ekir.2021.10.008. eCollection 2022 Jan. Kidney Int Rep. 2021. PMID: 35005312 Free PMC article.

2

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.

Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D. Bakris GL, et al. Among authors: agarwal r. Kidney Int. 2000 Nov;58(5):2084-92. doi: 10.1111/j.1523-1755.2000.00381.x. Kidney Int. 2000. PMID: 11044229 Free article. Clinical Trial.

3

A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.

Vasavada N, Saha C, Agarwal R. Vasavada N, et al. Among authors: agarwal r. Kidney Int. 2003 Aug;64(2):632-40. doi: 10.1046/j.1523-1755.2003.00124.x. Kidney Int. 2003. PMID: 12846760 Free article. Clinical Trial.

4

Role of excess volume in the pathophysiology of hypertension in chronic kidney disease.

Vasavada N, Agarwal R. Vasavada N, et al. Among authors: agarwal r. Kidney Int. 2003 Nov;64(5):1772-9. doi: 10.1046/j.1523-1755.2003.00273.x. Kidney Int. 2003. PMID: 14531810 Free article. Clinical Trial.

5

Antiproteinuric effect of oral paricalcitol in chronic kidney disease.

Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D. Agarwal R, et al. Kidney Int. 2005 Dec;68(6):2823-8. doi: 10.1111/j.1523-1755.2005.00755.x. Kidney Int. 2005. PMID: 16316359 Free article. Clinical Trial.

6

Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease.

Agarwal R, Andersen MJ. Agarwal R, et al. Kidney Int. 2006 Jan;69(2):406-11. doi: 10.1038/sj.ki.5000081. Kidney Int. 2006. PMID: 16408134 Free article.

7

Proinflammatory effects of iron sucrose in chronic kidney disease.

Agarwal R. Agarwal R. Kidney Int. 2006 Apr;69(7):1259-63. doi: 10.1038/sj.ki.5000164. Kidney Int. 2006. PMID: 16609688 Free article.

8

Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease.

Agarwal R, Rizkala AR, Kaskas MO, Minasian R, Trout JR. Agarwal R, et al. Kidney Int. 2007 Sep;72(5):638-42. doi: 10.1038/sj.ki.5002422. Epub 2007 Jul 11. Kidney Int. 2007. PMID: 17622274 Free article. Clinical Trial.

9

Are vitamin D receptor agonists like angiotensin-converting enzyme inhibitors without side effects?

Agarwal R. Agarwal R. Kidney Int. 2010 Jun;77(11):943-5. doi: 10.1038/ki.2010.77. Kidney Int. 2010. PMID: 20467430 Free article.

10

Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate.

Agarwal R, Hynson JE, Hecht TJ, Light RP, Sinha AD. Agarwal R, et al. Kidney Int. 2011 Nov;80(10):1073-9. doi: 10.1038/ki.2011.207. Epub 2011 Jun 29. Kidney Int. 2011. PMID: 21716260 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,261 results

Search Page

Filters